Protein discovery engine
FORGE combines phage display with a generative AI architecture to discover and optimize protein molecules.
Source: LinkedIn company description · Retrieved October 13, 2026
Gensaic develops tissue-selective ligands for targeted intracellular therapeutic delivery using AI-powered protein design and directed evolution.
Its portfolio advances therapies for metabolic and age-related diseases, initially focusing on siRNA payloads. Gensaic is based in Cambridge, Massachusetts, with a team of physicians, bioengineers, and machine learning scientists.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
FORGE combines phage display with a generative AI architecture to discover and optimize protein molecules.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 10, 2026, September 11, 2026, September 18, 2026, September 26, 2026, September 27, 2026 and September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.